Morgan Stanley Raises CME Group (NASDAQ:CME) Price Target to $220.00
CME Group (NASDAQ:CME – Free Report) had its target price upped by Morgan Stanley from $215.00 to $220.00 in a research report report published on Thursday, Benzinga reports. They currently have an equal weight rating on the financial services provider’s stock. Several other research analysts have also recently commented on the company. Rosenblatt Securities reissued […]
More Stories
Columbia Sportswear (NASDAQ:COLM) Issues Q3 Earnings Guidance
Columbia Sportswear (NASDAQ:COLM – Get Free Report) issued an update on its third quarter earnings guidance on Thursday morning. The...
Boston Beer (NYSE:SAM) Announces Quarterly Earnings Results
Boston Beer (NYSE:SAM – Get Free Report) posted its quarterly earnings data on Thursday. The company reported $4.39 earnings per...
Bitcoin Gold Market Cap Tops $457.42 Million (BTG)
Bitcoin Gold (BTG) traded up 4.7% against the dollar during the 1-day period ending at 22:00 PM Eastern on July...
AbbVie (NYSE:ABBV) Announces Quarterly Earnings Results, Beats Estimates By $0.08 EPS
AbbVie (NYSE:ABBV – Get Free Report) posted its earnings results on Thursday. The company reported $2.65 EPS for the quarter,...
Bluzelle (BLZ) Trading 8.7% Lower Over Last Week
Bluzelle (BLZ) traded up 1% against the U.S. dollar during the one day period ending at 22:00 PM E.T. on...
Bitcoin Diamond (BCD) Tops 24-Hour Volume of $4,433.51
Bitcoin Diamond (BCD) traded 10.4% higher against the dollar during the twenty-four hour period ending at 22:00 PM Eastern on...